Primary care REFerral for EchocaRdiogram (REFER) in heart failure: a diagnostic accuracy study
Authors:
- Fd Richard HobbsFHFd Richard Hobbs
- The REFER investigatorsTIThe REFER investigators
- J DeeksJDJ Deeks
- M R CowieMCM R Cowie
Open Access
- 5 December 2016
- journal article
- research article
- Published by Royal College of General Practitioners in British Journal of General Practice
- Vol. 67 (655) , e94-e102
Abstract
Background: Symptoms of breathlessness, fatigue, and ankle swelling are common in general practice but deciding which patients are likely to have heart failure is challenging.Aim: To evaluate the performance of a clinical decision rule (CDR), with or without N-Terminal pro-B type natriuretic peptide (NT-proBNP) assay, for identifying heart failure.Design and setting: Prospective, observational, diagnostic validation study of patients aged >55 years, presenting with shortness of breath, lethargy, or ankle oedema, from 28 general practices in England.Method: The outcome was test performance of the CDR and natriuretic peptide test in determining a diagnosis of heart failure. The reference standard was an expert consensus panel of three cardiologists.Results: Three hundred and four participants were recruited, with 104 (34.2%; 95% confidence interval [CI] = 28.9 to 39.8) having a confirmed diagnosis of heart failure. The CDR+NT-proBNP had a sensitivity of 90.4% (95% CI = 83.0 to 95.3) and specificity 45.5% (95% CI = 38.5 to 52.7). NT-proBNP level alone with a cut-off <400 pg/ml had sensitivity 76.9% (95% CI = 67.6 to 84.6) and specificity 91.5% (95% CI = 86.7 to 95.0). At the lower cut-off of NT-proBNP <125 pg/ml, sensitivity was 94.2% (95% CI = 87.9 to 97.9) and specificity 49.0% (95% CI = 41.9 to 56.1).Conclusion: At the low threshold of NT-proBNP <125 pg/ml, natriuretic peptide testing alone was better than a validated CDR+NT-proBNP in determining which patients presenting with symptoms went on to have a diagnosis of heart failure. The higher NT-proBNP threshold of 400 pg/ml may mean more than one in five patients with heart failure are not appropriately referred. Guideline natriuretic peptide thresholds may need to be revised.Keywords
This publication has 31 references indexed in Scilit:
- Performance of BNP and NT-proBNP for diagnosis of heart failure in primary care patients: a systematic reviewHeart Failure Reviews, 2014
- Using the CHADS2 and CHA2DS2-VASc Scores for Stroke Risk Prediction as well as the Identification of Stroke Outcomes and Cardiac Complications in Patients with and without Atrial FibrillationCerebrovascular Diseases, 2013
- Streptococcal pharyngitis in children: a meta-analysis of clinical decision rules and their clinical variablesBMJ Open, 2013
- Ten-Year Prognosis of Heart Failure in the Community: Follow-Up Data from the Echocardiographic Heart of England Screening (ECHOES) StudyEuropean Journal of Heart Failure, 2012
- The Diagnostic Accuracy of Plasma BNP and NTproBNP in Patients Referred From Primary Care with sUspected Heart Failure: Results of the UK Natriuretic Peptide StudyEuropean Journal of Heart Failure, 2005
- Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary diseaseEuropean Heart Journal, 2005
- Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative studyBMJ, 2003
- Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populationsBMJ, 2002
- Value of natriuretic peptides in assessment of patients with possible new heart failure in primary careThe Lancet, 1997
- Multicentre trial to introduce the Ottawa ankle rules for use of radiography in acute ankle injuriesBMJ, 1995